Drug Trial Radar · NCT07712562
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Aug 14, 2026
Primary completion
Apr 2029
Study completion Oct 2030
Sponsor
- Lead sponsor
- Dren BioIndustry
- Sponsor type
- Industry
- First posted
- Jul 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open-label, Phase 1/2 basket study to evaluate the safety and efficacy of Dibotatug (DR-01) in adults with Bone Marrow Failure syndromes.
Conditions
- Bone Marrow Failure Syndromes
- Aplastic Anemias
- Severe Aplastic Anemia (SAA)
- Severe Aplastic Anemia, Relapse
- Severe Aplastic Anemia, Refractory
- Non-severe Aplastic Anemia
Interventions
Dibotatug (DR-01)Drug
Dibotatug (DR-01) administered by IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate of Dibotatug (defined as proportion of subjects with a Complete Response or Partial Response) [Efficacy]Time frame: By 6 months
- Incidence and severity of adverse events as assessed by CTCAE v6.0 [Safety and Tolerability]Time frame: 52 weeks
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Dren Investigational Site
Duarte, California · Not yet recruiting
Dren Investigational Site
Palo Alto, California · Not yet recruiting
Dren Investigational Site
Miami, Florida · Not yet recruiting
Dren Investigational Site
Atlanta, Georgia · Recruiting
Dren Investigational Site
New York, New York · Recruiting
Dren Investigational Site
Cleveland, Ohio · Not yet recruiting
Dren Investigational Site
Columbus, Ohio · Not yet recruiting
Dren Investigational Site
Houston, Texas · Not yet recruiting
Dren Investigational Site
Fairfax, Virginia · Not yet recruiting
Dren Investigational Site
Seattle, Washington · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.